Dysregulationof miR-155-mediated STAT regulation may contribute to cancer progressionand resistance to therapy.59 It has beendemonstrated that miR-126 can moderate angiogenesis through inhibiting VEGFA in BC.60 miRNet analysisalso indicated that ZEB1 is a target gene of miR-200cin BC. This evidence concerns the gene ZEB1 and breast cancer.